Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
Little is known about the relative importance of monocyte and tissue-resident macrophages in the development of lung fibrosis. We show that specific genetic deletion of monocyte-derived alveolar macrophages after their recruitment to the lung ameliorated lung fibrosis, whereas tissue-resident alveolar macrophages did not contribute to fibrosis. Using transcriptomic profiling of flow-sorted cells, we found that monocyte to alveolar macrophage differentiation unfolds continuously over the course of fibrosis and its resolution. During the fibrotic phase, monocyte-derived alveolar macrophages differ significantly from tissue-resident alveolar macrophages in their expression of profibrotic genes. A population of monocyte-derived alveolar macrophages persisted in the lung for one year after the resolution of fibrosis, where they became increasingly similar to tissue-resident alveolar macrophages. Human homologues of profibrotic genes expressed by mouse monocyte-derived alveolar macrophages during fibrosis were up-regulated in human alveolar macrophages from fibrotic compared with normal lungs. Our findings suggest that selectively targeting alveolar macrophage differentiation within the lung may ameliorate fibrosis without the adverse consequences associated with global monocyte or tissue-resident alveolar macrophage depletion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies suggest that the latter effect is at least in part due to the contribution of pro-fibrotic macrophages to the activation of fibroblasts into to myofibroblasts in a process that depends on physical contact (14, 15).”
From Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy (2024) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Following tissue injury, many resident macrophages die, and the lung parenchyma initiates an innate immune response characterized by the differentiation of bone marrow-derived monocytes to supplement the macrophage pool 61.”
From Nicotinamide phosphoribosyltransferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice (2024) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The pathogenic role of Mo-AMs in lung fibrosis has been largely attributed to their activity in producing a number of pro-fibrotic mediators, such as TGF-β, PDGF-α, osteopontin (OPN), and MMPs1,3,11,13,15,18,28.”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“depletion of Mo-AMs via several strategies conferred protection from lung fibrosis in multiple mouse models1,3,10,11,13,20”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Mo-AMs, but not TR-AMs, are responsible for the pro-fibrotic activity of this group of cells1,3,10,13”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [1]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364 · cited 2×
“, 2013), and differential gene expression was assessed using edgeR (Robinson et al., 2010; McCarthy et al., 2012) R/Bioconductor packages.”
MethodMacrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
McCarthy, D. J., Chen, Y., & Smyth, G. K. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks042 · Cited by 5,195 · cited 2×
“, 2013), and differential gene expression was assessed using edgeR (Robinson et al., 2010; McCarthy et al., 2012) R/Bioconductor packages.”
MethodThe M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689 · cited 1×
“Macrophage polarization refers to distinct sets of inflammatory (M1) or fibrotic (M2) genes that are expressed by macrophages in cell culture that are first induced toward differentiation and then treated with LPS and IFN-γ or IL-4, respectively (Martinez and Gordon, 2014; Murray et al., 2014).”
BackgroundMacrophages in Tissue Repair, Regeneration, and Fibrosis
Wynn, T. A., & Vannella, K. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.015 · Cited by 4,481
Software for Computing and Annotating Genomic Ranges
Lawrence, M., Huber, W., Pagès, H., Aboyoun, P., Carlson, M., Gentleman, R., Morgan, M. T., & Carey, V. J. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003118 · Cited by 4,398 · cited 3×
“…using FastQC, reads were trimmed and aligned to mm10 reference genome using TopHat2, read counts were associated with genes using the GenomicRanges (Lawrence et al., 2013), and differential gene expression was assessed using edgeR (Robinson et al., 2010; McCarthy et al., 2012) R/Bioconductor…”
MethodInfluentialGOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eden, E., Navon, R., Steinfeld, I., Lipson, D., & Yakhini, Z. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-48 · Cited by 3,356
Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
Yona, S., Kim, K.-W., Wolf, Y., Mildner, A., Varol, D., Breker, M., Strauss-Ayali, D., Viukov, S., Guilliams, M., Misharin, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.001 · Cited by 3,245 · cited 2×
“2387 IntroductIon Van Furth and colleagues suggested an adult monocytic origin of all macrophages, but it is now clear that many tissue-resident macrophages, including alveolar macrophages in the lung, are self-renewing populations that arise from fetal progenitors and require minimal input from circuiting adult monoc…”
BackgroundSelf-citationHashimoto, D., Chow, A., Noizat, C., Teo, P., Beasley, M. B., Leboeuf, M., Becker, C. D., See, P., Price, J., Lucas, D., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.004 · Cited by 2,311 · cited 3×
“Extending the findings from several groups (Guilliams et al., 2013; Hashimoto et al., 2013; van de Laar et al., 2016), we found that TR-AMs were remarkably stable, constituting >95% of alveolar macrophages at 14 mo of age (Fig.”
BackgroundTranscriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., De Nardo, D., Gohel, T. D., Emde, M., Schmidleithner, L., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.006 · Cited by 2,210 · cited 1×
“This “macrophage polarization” model is based on limited evidence and is conceptually incomplete (Xue et al., 2014; Nahrendorf and Swirski, 2016).”
Background
Cited by
Items 501–600 of 998
Fernandez‐Gonzalez, A., Mukhia, A., Nadkarni, J., Willis, G. R., Reis, M., Zhumka, K., Vitali, S. H., Liu, X., Galls, A., Mitsialis, S. A., et al. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.321264 · Cited by 26
“…neutrophil accumulation, and loss of epithelial barrier function in a model of acute lung injury 39 and are critical for the resolution of bleomycin-induced lung injury during the fibrotic period 40 and the regression of vascular remodeling induced by subchronic exposure to hemoglobin and hypoxia.”
Macrophages and the microbiome in chronic obstructive pulmonary disease
Sandhu, K. K., Scott, A., Tatler, A. L., Belchamber, K. B. R., & Cox, M. J. (2024) · European Respiratory Review · doi:10.1183/16000617.0053-2024 · Cited by 25
“Macrophages from the periphery will not have had the same complex prior exposures as AMs and are likely to be pro-inflammatory [17]; we might expect them to respond to the microbiota differently.”
Isolation and Characterization of Mononuclear Phagocytes in the Mouse Lung and Lymph Nodes
Gibbings, S. L., & Jakubzick, C. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8570-8_3 · Cited by 24
Breathing fresh air into respiratory research with single-cell RNA sequencing
Alexander, M. J., Budinger, G. R. S., & Reyfman, P. A. (2020) · European Respiratory Review · doi:10.1183/16000617.0060-2020 · Cited by 24
“In murine models of bleomycin- and asbestos-induced fibrosis, we found that monocytederived alveolar macrophages recruited in response to lung injury were necessary for fibrosis, while tissue-resident alveolar macrophages were dispensable [21, 22].”
BackgroundSelf-citationZhang, N., Yang, K., Bai, J., Yi, J., Gao, C.-C., Zhao, J.-L., Liang, S.-Q., Wei, T.-X., Feng, L., Song, L.-Q., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201903086rr · Cited by 16
NOX4 regulates macrophage apoptosis resistance to induce fibrotic progression
Larson‐Casey, J. L., Gu, L., Kang, J., Dhyani, A., & Carter, A. B. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100810 · Cited by 26
Morrell, E. D., Holton, S. E., Lawrance, M., Orlov, M., Franklin, Z., Mitchem, M. A., DeBerg, H., Gersuk, V. H., Garay, A., Barnes, E., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43223-0 · Cited by 20
“For example, mature CD206 + alveolar macrophages collected from participants with idiopathic pulmonary fi brosis have much higher expression of pro fi brotic genes such as APOE and MMP12 compared with CD206 + alveolar macrophages from healthy donors 6 .”
Influentialde Cevins, C., Delage, L., Batignes, M., Riller, Q., Luka, M., Rémaury, A., Sorin, B., Fali, T., Masson, C., Hoareau‐Coudert, B., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101333 · Cited by 31
The role of macrophages in asthma-related fibrosis and remodelling
Yang, X., Li, F., Zhang, G., Foster, P. S., & Yang, M. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108820 · Cited by 22
Jiang, Y., Zhang, L., Lin, Y., Zhu, X., Wang, T., Zhu, Z., Chen, Y., & Tang, D. (2025) · Molecules and Cells · doi:10.1016/j.mocell.2025.100264 · Cited by 26
“Selective targeting of AM differentiation ameliorates fibrosis without depleting monocytes or resident macrophages (Misharin et al., 2017), highlighting the therapeutic potential of ferroptosis inhibitors and iron chelators in PF treatment based on AMs.”
Post‐translational regulation of PGC‐1α modulates fibrotic repair
Larson‐Casey, J. L., Gu, L., Davis, D., Cai, G., Ding, Q., He, C., & Carter, A. B. (2021) · The FASEB Journal · doi:10.1096/fj.202100339r · Cited by 24
Chung, C., Kim, J., Cho, H. S., & Kim, H. C. (2022) · Scientific Reports · doi:10.1038/s41598-022-12399-8 · Cited by 27
Novel tracers for molecular imaging of interstitial lung disease: A state of the art review
Broens, B., Duitman, J., Zwezerijnen, G. J. C., Nossent, E. J., van der Laken, C. J., & Voskuyl, A. E. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103202 · Cited by 21
Rodriguez-Rodriguez, L., Gillet, L., & Machiels, B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1149015 · Cited by 23
Human macrophages and innate lymphoid cells: Tissue-resident innate immunity in humanized mice
Alisjahbana, A., Mohammad, I., Gao, Y., Evren, E., Ringqvist, E. E., & Willinger, T. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113672 · Cited by 23
Wu, J., Wang, X., Zhou, M., Chen, G., Du, J., Wang, Y., & Ye, C. (2021) · BMC Pediatrics · doi:10.1186/s12887-021-03018-y · Cited by 26
Myeloid Fbxw7 Prevents Pulmonary Fibrosis by Suppressing TGF-β Production
He, J., Du, Y. J., Li, G., Xiao, P., Sun, X., Song, W., Lai, L., Meng, X., Zhang, J., & Wang, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.760138 · Cited by 26
Targeting the Myofibroblast in Pulmonary Fibrosis
Misharin, A. V., & Budinger, G. R. S. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201806-1037ed · Cited by 24
Self-citationMoos, P. J., Cheminant, J. R., Cowman, S. J., Noll, J., Wang, Q.-M., Musci, T. S., & Venosa, A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1425466 · Cited by 23
Alveolar Macrophages in Viral Respiratory Infections: Sentinels and Saboteurs of Lung Defense
Pöpperl, P., Stoff, M., & Beineke, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010407 · Cited by 23
“However, functional alterations of these recruited AlvM ϕ can be either beneficial or detrimental for lung homeostasis, host defense, and tissue repair following respiratory infection [63,64,71,72].”
Innate immune memory: The evolving role of macrophages in therapy
Damani‐Yokota, P., & Khanna, K. M. (2025) · eLife · doi:10.7554/elife.108276 · Cited by 26
“…trained immunity for a rapid, localized responses to secondary infections ( Li et al., 2022b ; Aegerter et al., 2020 ; Chen et al., 2023b ; Feuerstein et al., 2020 ; Leopold Wager and Schlesinger, 2025 ; Zahalka et al., 2022 ; Chen et al., 2022a ; Misharin et al., 2017 ; Wang et al., 2023 ).”
Wang, Y., Guo, Z., Ma, R., Wang, J., Wu, N., Fan, Y., & Ye, Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.924754 · Cited by 22
“In addition, peripheral blood monocyte counts have been investigated in IPF and other ILDs as a predictor of prognosis (Misharin et al., 2017; Barratt et al., 2021).”
BackgroundWen, Y., Wang, X., Meng, W., Guo, W., Duan, C., Cao, J., Kang, L., Guo, N., Lin, Q., Lv, P., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202200434rr · Cited by 22
Alveolar macrophage modulation via the gut–lung axis in lung diseases
Chen, Z., Liu, Y., & Huang, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1279677 · Cited by 20
Plasticity and crosstalk of mesenchymal stem cells and macrophages in immunomodulation in sepsis
Tao, X., Wang, J., Liu, B., Cheng, P.-F., Mu, D., Du, H., & Niu, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1338744 · Cited by 22
Maintenance of homeostasis by TLR4 ligands
Oda, M., Yamamoto, H., & Kawakami, T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1286270 · Cited by 22
Inducible CCR2+ nonclassical monocytes mediate the regression of cancer metastasis
Liu, X., Ren, Z., Tan, C., Nunez-Santana, F., Kelly, M. E., Yan, Y., Sun, H., Abdala‐Valencia, H., Yang, W., Wu, Q., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci179527 · Cited by 21
“Murine tissues were processed for flow cytometry analysis or adoptive transfer as described previously (66–68).”
Self-citationDifferential expression of genes and receptors in monocytes from patients with cystic fibrosis
Tarique, A. A., Sly, P. D., Cardenas, D. G., Luo, L., Stow, J. L., Bell, S. C., Wainwright, C. E., & Fantino, E. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.07.012 · Cited by 21
Liu, Y., Saito, S., Morris, G. F., Miller, C. A., Li, J., & Lefante, J. J. (2018) · Genomics · doi:10.1016/j.ygeno.2018.09.006 · Cited by 22
Management of Idiopathic Pulmonary Fibrosis
Salisbury, M. L., & Wijsenbeek, M. S. (2021) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2021.03.004 · Cited by 20
Latitudinal and longitudinal regulation of tissue macrophages in inflammatory diseases
He, X.-Y., Tan, S., Shao, Z., & Wang, X. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.06.007 · Cited by 22
lincRNA-Cox2 Functions to Regulate Inflammation in Alveolar Macrophages during Acute Lung Injury
Robinson, E. K., Worthington, A. K., Poscablo, D. M., Shapleigh, B., Salih, M. M., Halasz, H., Seninge, L., Mosqueira, B., Smaliy, V., Forsberg, E. C., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100743 · Cited by 19
The immune mechanisms of acute exacerbations of idiopathic pulmonary fibrosis
Chen, T., Sun, W., & Xu, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1450688 · Cited by 22
Woods, P. S., & Mutlu, G. M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1535796 · Cited by 23
Self-citationAstrab, L. R., Skelton, M. L., & Caliari, S. R. (2025) · Cell Biomaterials · doi:10.1016/j.celbio.2025.100052 · Cited by 24
Brazee, P. L., Allen, N., Knipe, R. S., Redente, E. F., & Saux, C. J. L. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2649-9402 · Cited by 27
“16 Macrophages also play a role in the maintenance of fi brosis once it is established, as macrophage depletion in this context has been shown to accelerate fi brosis resolution.”
Feo-Lucas, L., Godio, C., de la Escalera, M. M., Ladrón, N. Á., Villarrubia, L. H., Vega‐Pérez, A., González-Cintado, L., Domínguez‐Andrés, J., García-Fojeda, B., Montero-Fernández, C., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1125984 · Cited by 18
“New-AMØs were proposed, but not demonstrated, to be monocyte-derived, during herpes virus infection (26) or experimental fibrosis (25).”
BackgroundInfluentialZhu, J., Jiang, Q., Gao, S., Xia, Q., Zhang, H., Liu, B., Zhao, R., Jiang, H., Li, X., Xu, A., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107178 · Cited by 22
The role of alveolar macrophages in viral respiratory infections and their therapeutic implications
Javaherdehi, A. P., Ghanbari, S., Mahdavi, P., Zafarani, A., & Razizadeh, M. H. (2024) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2024.101826 · Cited by 33
“Interestingly, Research indicates that monocyte-driven AMs are the primary cells involved in this process, as they express genes associated with fibrosis [66].”
BackgroundWang, Z., Wang, Y., Yan, Q., Cai, C., Feng, Y., Huang, Q., Li, T., Yuan, S., Huang, J., Luo, Z.-H., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-07025-4 · Cited by 22
2-Methoxyestradiol Inhibits Radiation-Induced Skin Injuries
Kim, J.-H., Nam, J.-K., Kim, A., Park, M., Lee, H., Park, J., Kim, J., & Lee, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084171 · Cited by 19
“2-ME, which has been approved by the FDA as an anti-cancer drug, is known to have anti-angiogenic effects and to target HIF-1α [28], and it is used to treat breast, prostate, and ovarian cancer in clinical trials [16,29,30].”
BackgroundKang, H., Gu, X., Cao, S., Tong, Z., & Song, N. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116899 · Cited by 18
Immune-epithelial cell interactions in lung development, homeostasis and disease
Yoshida, M., Arzili, R., & Nikolić, M. (2024) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2024.106703 · Cited by 19
“…fibrosis, selective genetic deletion of monocyte-derived alveolar macrophages improved fibrosis outcomes, further suggesting their pro-fibrotic role 65,66 . o o Single cell RNA-seq analysis of human fibrotic lung tissue revealed the presence of monocyte-derived alveolar macrophages with…”
Innate type 2 lymphocytes trigger an inflammatory switch in alveolar macrophages
Verwaerde, S., Hastir, J., Schetters, S. T. T., Smole, U., Seys, L., Baptista, A. P., English, K., Schuijs, M. J., Aegerter, H., Damme, K. F. A. V., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.11.015 · Cited by 21
Cyr-Depauw, C., Hurskainen, M., Vadivel, A., Mižíková, I., Lesage, F., & Thébaud, B. (2020) · Pediatric Research · doi:10.1038/s41390-020-0967-6 · Cited by 18
Cadherin-11 Regulates Macrophage Development and Function
To, S., Chavula, T., Pedroza, M., Smith, J., & Agarwal, S. K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.795337 · Cited by 18
“At steady state, lung macrophages have been found to express both M1 and M2 markers (5, 12).”
BackgroundEarly-wave macrophages control late hematopoiesis
Monticelli, S., Sommer, A., Hassan, Z. A., Rodriguez, C. G., Adé, K., Cattenoz, P. B., Delaporte, C., Perdiguero, E. G., & Giangrande, A. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.03.013 · Cited by 18
Yan, J., Zeng, Q., & Wang, X. (2024) · BMC Bioinformatics · doi:10.1186/s12859-024-05889-1 · Cited by 21
“To test the performance of our algorithm on weak-signal detection, we used the GSE82158 dataset provided by Misharin et al. [41].”
BackgroundMethodAlfaro, E., Casitas, R., Díaz‐García, E., García-Tovar, S., Galera, R., Torres-Vargas, M., Peña, M. F.-V., López-Fernández, C., Añón, J. M., Quintana‐Díaz, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1401015 · Cited by 17
Single-cell sequencing edges into clinical trials
Keener, A. B. (2019) · Nature Medicine · doi:10.1038/d41591-019-00017-6 · Cited by 17
Duan, M., Yang, Y., Peng, S., Liu, X., Zhong, J., Guo, Y., Lu, M., Nie, H., Ren, B., Zhang, X., et al. (2019) · Journal of Immunology Research · doi:10.1155/2019/5148575 · Cited by 20
“japonicum infection, and animal studies have shown that M2 macrophages may exhibit as a novel target for the prevention and treatment of fibrosis [14].”
BackgroundEndogenous Long Pentraxin 3 Exerts a Protective Role in a Murine Model of Pulmonary Fibrosis
Maccarinelli, F., Bugatti, M., Schuind, A. C., Ganzerla, S., Vermi, W., Presta, M., & Ronca, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.617671 · Cited by 17
“Even though little is known about the role of monocytes and tissue-resident macrophages in lung fibrosis (8), macrophages are persistently increased in the lung in close proximity to collagen-producing fibroblasts, in keeping with the role exerted by monocytes in the development of experimental fibrosis (9, 10).”
BackgroundBarratt, S. L., Creamer, A. W., Adamali, H. I., Duckworth, A., Fallon, J., Fidan, S., Nancarrow, T., Wollerton, R. L., Steward, M., Gooptu, B., et al. (2021) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2021-001063 · Cited by 16
Li, C. R., He, Y., Zhang, Y., You, Y., Yuan, H.-Y., Wei, Y., Chen, X., & Chen, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113173 · Cited by 17
Role of oxygen sensing and hypoxia-inducible factors in orchestrating innate immune responses
Low, J. T., Kim, Y., Matsushita, M., & Ho, P. (2025) · Nature Immunology · doi:10.1038/s41590-025-02317-1 · Cited by 23
“Notably, monocyte-derived alveolar macrophages express profibrotic gene signatures and drive the progression of bleomycin-induced lung fibrosis, whereas resident alveolar macrophages do not contribute to this pathology 79 .”
Immunometabolic programming of macrophages in asthma pathogenesis and therapy
Lu, L., Shi, M., Wen, Q., Yang, M., Wang, X. C., & Wang, Y. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2025.1736340 · Cited by 20
Lineage tracing reveals the origins and dynamics of macrophages in lung injury and repair
Jin, H., Mou, J., Zhu, H., Liu, K., Zhang, M., Zhang, Z., Pflanz, S., Kasmi, K. E., Liu, Z., Ginhoux, F., et al. (2026) · Cell Discovery · doi:10.1038/s41421-025-00859-0 · Cited by 18
“Mice of the indicated genotypes were assigned randomly to the experimental groups.”
Rochford, I., Joshi, J. C., Rayees, S., Anwar, M., Akhter, M. Z., Yalagala, V. L., Banerjee, S., & Mehta, D. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00145.2021 · Cited by 15
Monocyte signature as a predictor of chronic lung disease in the preterm infant
Windhorst, A., Heydarian, M., Schwarz, M., Oak, P., Förster, K. M., Frankenberger, M., González, E. G., Zhang, X., Ehrhardt, H., Hübener, C., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1112608 · Cited by 20
“5 (34-59) 9 (1-48) 50 (0-119) 2 (1-13) 11 (3-45)”
BackgroundInfluentialHolloman, B. L., Wilson, K. M., Cannon, A. S., Nagarkatti, M., & Nagarkatti, P. S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1330373 · Cited by 18
Noninvasive assessment of the lung inflammation-fibrosis axis by targeted imaging of CMKLR1
Mannes, P. Z., Adams, T. S., Farsijani, S., Barnes, C. E., Latoche, J. D., Day, K. E., Nedrow, J. R., Ahangari, F., Kaminski, N., Lee, J. S., et al. (2024) · Science Advances · doi:10.1126/sciadv.adm9817 · Cited by 17
Zheng, M., Zhou, Z., Tian, X.-T., Xiao, D., Hou, X., Xie, Z., Liang, H., & Lin, S. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02627-3 · Cited by 18
Toki, S., Zhou, W., Goleniewska, K., Reiss, S., Dulek, D. E., Newcomb, D. C., Lawson, W. E., & Peebles, R. S. (2018) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2018.04.001 · Cited by 16
Reexamining the Role of Pulmonary Lipids in the Pathogenesis of Pulmonary Fibrosis
O’Callaghan, M., Tarling, E. J., Bridges, J. P., Redente, E. F., Byrne, A. J., Keane, M. P., & McCarthy, C. (2024) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2024-0124ps · Cited by 16
Szczepan, M., Llorián‐Salvador, M., Yi, C., Hughes, D., Mack, M., Chen, M., & Xu, H. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.3.41 · Cited by 17
“33 We have shown that infiltrating macrophages can promote subretinal fibrosis through MMT, 18 a process involving macrophage elastase (MMP-12).”
The PERK/ATF4 pathway is required for metabolic reprogramming and progressive lung fibrosis
Pandey, J., Larson‐Casey, J. L., Patil, M. H., He, C., Pinthong, N., & Carter, A. B. (2025) · JCI Insight · doi:10.1172/jci.insight.189330 · Cited by 17
“Monocyte-derived macrophages (MDMs) drive fibrotic lung remodeling and mediate disease progression through the expression and secretion of profibrotic mediators (13-15).”
Profibrotic impact of PAD4-driven macrophage extracellular traps in ulcerative colitis
Wang, Z., Shi, R., Shi, Y., Sun, T., Shen, Y., Wu, C., Yang, Y., Fan, H., & Wu, J. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107933 · Cited by 17
Tissue regeneration: Unraveling strategies for resolving pathological fibrosis
Li, J., Wang, S., Yuan, J., Mao, X., Wang, X., Zhang, L., Dong, Q., Chen, Z., Wang, Y., & Tang, N. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.10.002 · Cited by 23
Idiopathic Pulmonary Fibrosis: Cellular Heterogeneity, Mechanisms, and Therapeutic Implications
Zuo, L., Liu, Q., Ye, D., Fan, J., & Wu, L. (2025) · MedComm · doi:10.1002/mco2.70521 · Cited by 21
Fibroblasts as regulators of lung immunity, repair and fibrosis
Bell, P. T., & Belz, G. T. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01268-4 · Cited by 21
“96,99,102,103).”
Lee, K. M., Morris‐Love, J., Cabral, D. J., Belenky, P. A., Opal, S. M., & Jamieson, A. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02377 · Cited by 16
Targeted Accumulation of Macrophages Induced by Microbeam Irradiation in a Tissue-Dependent Manner
Trappetti, V., Fazzari, J., Fernández-Palomo, C., Smyth, L. M. L., Potez, M., Shintani, N., Dietler, B. D. B., Martin, O. A., & Djonov, V. (2022) · Biomedicines · doi:10.3390/biomedicines10040735 · Cited by 14
“When the injury is extensive, monocyte-derived alveolar macrophages support the onset of chronic inflammation [14] and subsequent fibrosis [52].”
BackgroundCui, Y., Gutiérrez, S., Ariai, S., Öberg, L., Thörn, K., Gehrmann, U., Cloonan, S., Naessens, T., & Olsson, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.998059 · Cited by 12
Liu, X., Zeng, L., Zhou, Y., Zhao, X., Zhu, L., Zhang, J., Pan, Y., Shao, C., & Fu, J. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04177-5 · Cited by 17
“Restricting the infiltration of macrophages into the lung tissues can attenuate pulmonary fibrosis by limiting collagen production and fibrotic remodeling in the BIPF model [34, 54].”
BackgroundIs there a role for specialized pro-resolving mediators in pulmonary fibrosis?
Thatcher, T. H., Freeberg, M. A. T., Myo, Y. P. A., & Sime, P. J. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108460 · Cited by 15
Ysasi, A. B., Engler, A., Bawa, P., Wang, F., Conrad, R. D., Yeung, A. K., Rock, J. R., Beane, J., Mazzilli, S. A., Franklin, R. A., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110169 · Cited by 15
Özkan, M., Eskiocak, Y. C., & Wingender, G. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250533 · Cited by 14
Li, F., Okreglicka, K. M., Piattini, F., Pohlmeier, L. M., Schneider, C., & Köpf, M. (2022) · JCI Insight · doi:10.1172/jci.insight.152271 · Cited by 15
Effendi, W. I., & Nagano, T. (2023) · Biomedicines · doi:10.3390/biomedicines11041047 · Cited by 18
Zinc Deficiency Induces Oxidative Damage and Causes Spleen Fibrosis
Zhang, Q., Zhang, H., Chen, Y., Wang, Y., Yang, M., & Guo, M. (2019) · Biological Trace Element Research · doi:10.1007/s12011-019-01762-y · Cited by 16
Kulshrestha, R., Dhanda, H., Pandey, A., Singh, A. K., & Kumar, R. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1776117 · Cited by 15
Stuck in a Moment: Does Abnormal Persistence of Epithelial Progenitors Drive Pulmonary Fibrosis?
Auyeung, V. C., & Sheppard, D. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202010-3898ed · Cited by 17
“Others are inflammatory chemokines that could help recruit monocyte-derived macrophages that infiltrate fibrotic regions and can, in turn, help support the proliferation and activation of fibroblasts (12, 13).”
BackgroundOkabe, Y., Toda, E., Urushiyama, H., Terashima, Y., Kunugi, S., Kajimoto, Y., Terasaki, M., Matsushima, K., Saito, A., Yamauchi, Y., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-71770-z · Cited by 14
Farooq, H., Luehmann, H. P., Koenitzer, J. R., Heo, G. S., Sultan, D. H., Kulkarni, D. H., Gunsten, S. P., Sashti, R. M., Huang, T., Keller, A. R., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105431 · Cited by 16
The Interplay Between Innate Immunity and Nonimmune Cells in Lung Damage, Inflammation, and Repair
Iliakis, C. S., Crotta, S., & Wack, A. (2025) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082323-031852 · Cited by 20
New Insights into SARS-CoV-2 and Cancer Cross-Talk: Does a Novel Oncogenesis Driver Emerge?
Rapti, V., Τσαγανός, Θ., Vathiotis, I. A., Syrigos, N. K., Li, P., & Poulakou, G. (2022) · Vaccines · doi:10.3390/vaccines10101607 · Cited by 16
Influence of the irradiated pulmonary microenvironment on macrophage and T cell dynamics
Groves, A. M., Misra, R. S., Clair, G., Hernady, E., Olson, H. M., Orton, D., Finkelstein, J. N., Marples, B., & Johnston, C. J. (2023) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2023.109543 · Cited by 14
Cigarette Smoking, and Blood Monocyte Count Correlate with Chronic Lung Injuries and Mortality
Sangani, R. G., Deepak, V., Anwar, J., Patel, Z., & Ghio, A. J. (2023) · International Journal of COPD · doi:10.2147/copd.s397667 · Cited by 17
“This is comparable to the results of investigation which supports an involvement of monocyte-derived macrophages in the development of lung fibrosis.(33,47,53,54) Lastly, emphysema (irreversible cell death) can manifest histologically during early years of smoking (CPY≥10 and onwards) but it became the most prominent…”
ResultHuckestein, B. R., Zeng, K., Westcott, R., Alder, J. K., Antos, D., Kolls, J. K., & Alcorn, J. F. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.11.017 · Cited by 16
Metabolism-driven glycosylation represents therapeutic opportunities in interstitial lung diseases
Drzewicka, K., & Zasłona, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1328781 · Cited by 13
Ishii, D., Kawasaki, T., Sato, H., Tatsumi, K., Imamoto, T., Yoshioka, K., Abe, M., Hasegawa, Y., Ohara, O., & Suzuki, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073750 · Cited by 15
“A recent and growing body of literature has described the key role of immune cells in orchestrating cell–cell interactions, including the crosstalk between epithelial cells and fibroblasts [9–11].”
BackgroundCD47-mediated immune evasion in early-stage lung cancer progression
Chuang, C., Zhen, Y., Ma, J.-Y., Lee, T.-H., Hung, H.-Y., Wu, C.-C., Wang, P., Huang, C.-T., Huang, M.-S., Hsiao, M., et al. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150066 · Cited by 15
The role of RNA m6A demethylase ALKBH5 in the mechanisms of fibrosis
Liao, Z., Wang, J., Xu, M., Li, X., & Xu, H. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1447135 · Cited by 17
Sinclair, K. A., Yerkovich, S. T., Hopkins, P. M.-A., Fieuw, A. M., Ford, P., Powell, J. E., O’Sullivan, B., & Chambers, D. C. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.10.005 · Cited by 15
MCCLAIN-CALDWELL, I., Hogden, C. T., Németh, K., Boyajian, M., Krepuska, M., Szombath, G., MacDonald, S. D., Abshari, M., Moss, J., Vitale-Cross, L. A., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010278 · Cited by 14
“Interestingly, in mice, the ontogeny of the macrophages appears to be crucial for the development of fibrosis [52].”
BackgroundNémeth, J., Schundner, A., & Frick, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.611728 · Cited by 17
“Murine models of bleomycin-induced fibrosis suggested that (monocyte-derived) macrophages could contribute to progression of fibrosis through overreactive responses to alveolar injury (42, 43).”
BackgroundSingle‐Cell Insights Into Macrophage Subtypes in Pulmonary Infections
Lin, Z., Zheng, Y., Zhong, Y., & Wang, H. (2026) · Advanced Science · doi:10.1002/advs.202510758 · Cited by 13
Yang, Y.-M., Ding, Y.-F., Hu, Y.-Y., Fan, F., & Zhao, J.-L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1723270 · Cited by 18
Nguyen, J., Armstrong, B. S., Cowman, S. J., Tomer, Y., Veerabhadraiah, S. R., Beers, M. F., & Venosa, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.875887 · Cited by 13
“Monocyte-derived moieties, gated on CD64 high, CD11c high, SiglecF low expression was recently linked to pro-fibrotic remodeling following blemycin-induced lung injury (Misharin et al., 2017; Joshi et al., 2020).”
BackgroundResultInfluentialHDM induces distinct immunometabolic phenotype in macrophages in TLR4-dependent manner
Yurakova, T. R., Gubernatorova, E. O., Gorshkova, E. A., Nosenko, M. A., Nedospasov, S. A., & Drutskaya, M. S. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166531 · Cited by 13
Metadata
- Authors
- Misharin, A. V., Morales-Nebreda, L., Reyfman, P. A., Cuda, C. M., Walter, J. M., McQuattie-Pimentel, A. C., Chen, C.-I., Anekalla, K. R., Joshi, N., Williams, K. J. N., Abdala-Valencia, H., Yacoub, T. J., Chi, M., Chiu, S., Gonzalez-Gonzalez, F. J., Gates, K., Lam, A. P., Nicholson, T. T., Homan, P. J., Soberanes, S., Dominguez, S., Morgan, V. K., Saber, R., Shaffer, A., Hinchcliff, M., Marshall, S. A., Bharat, A., Berdnikovs, S., Bhorade, S. M., Bartom, E. T., Morimoto, R. I., Balch, W. E., Sznajder, J. I., Chandel, N. S., Mutlu, G. M., Jain, M., Gottardi, C. J., Singer, B. D., Ridge, K. M., Bagheri, N., Shilatifard, A., Budinger, G. R. S., & Perlman, H.
- Affiliations
- Northwestern University (US)
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 1
- Division of Rheumatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 2
- Scripps Research Institute (US)
- University of Chicago (US)
- Corresponding author
- Perlman, Harris
- ORCID
- Misharin, Alexander V.
- Reyfman, Paul A.
- Cuda, Carla M.
- Walter, James M.
- McQuattie-Pimentel, Alexandra C.
- Chen, Ching-I
- Anekalla, Kishore R.
- Joshi, Nikita
- Chiu, Stephen
- Gonzalez-Gonzalez, Francisco J.
- Lam, Anna P.
- Nicholson, Trevor T.
- Homan, Philip J.
- Soberanes, Saul
- Dominguez, Salina
- Morgan, Vince K.
- Saber, Rana
- Shaffer, Alexander
- Hinchcliff, Monique
- Marshall, Stacy A.
- Bharat, Ankit
- Berdnikovs, Sergejs
- Bhorade, Sangeeta M.
- Bartom, Elizabeth T.
- Morimoto, Richard I.
- Balch, William E.
- Sznajder, Jacob I.
- Chandel, Navdeep S.
- Mutlu, Gökhan M.
- Jain, Manu
- Gottardi, Cara J.
- Singer, Benjamin D.
- Ridge, Karen M.
- Bagheri, Neda
- Shilatifard, Ali
- Budinger, G.R. Scott
- Perlman, Harris
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-07-10
- Volume
- 214
- Issue
- 8
- Pages
- 2387-2404
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5551573
- OpenAlex
- W2736034593
- Cited by
- 1,133
- References
- 87
- Citations by year
- 2026: 139 · 2025: 131 · 2024: 156 · 2023: 135 · 2022: 136 · 2021: 128 · 2020: 134 · 2019: 81 · 2018: 77 · 2017: 15
- FWCI
- 68.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- NIH (AR064313, HL128867, T32 DK077662, HL125940, AG049665, HL048129, HL071643, HL085534, ES015024, ES025644, HL079190, HL124664, ES013995, AR064546, HL134375)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR061593)
- Scleroderma Foundation
- Department of Defense (PR141319)
- BD Bioscience
- Northwestern University (5T32 HL076139-13)
- American Society for Transplant Surgery Foundation
- Thoracic Surgery Foundation
- Society of University Surgeons
- American Association of Thoracic Surgery
- Parker B. Francis
- Veterans Administration (BX000201)
- Mabel Greene Myers
- National Cancer Institute (P30 CA060553)
- Feinberg School of Medicine
- American Thoracic Society
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- pulmonary fibrosis, alveolar macrophages, monocyte-derived macrophages, tissue-resident macrophages, monocyte-to-macrophage differentiation, fibrosis resolution, gene deletion, gene expression profiling
- MeSH terms
- Animals, Cell Differentiation, Fibrosis, Humans, Lung, Monocytes, Macrophages, Alveolar, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.